LID27 Oct 2011 18:34
If I read interims correctly, they have about £1.1 million in the bank, inventory went up by £200K so they have stock to satisfy orders, and operating costs reduced by a whopping 58%, to £245K (whereas Deltex's went up by £99K to £696K). The integration of Covidien's DOA (depthof Anaesthesia) will give Lidco a unique advantage, and they now have distribution rights to Argon's critical care product lines in the UK. "Early results suggest this [Argon] will become a significant source of revenue." I actually bought a few more today, so I'm obviously bullish. After more than 8years of waiting, I now reckon I'm in with a fighting chance of getting a fair bit more than my money back!